The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I–III colorectal cancer

This study aimed to assess the relationship between the Cancer-Inflammation Prognostic Index (CIPI) and disease-free survival (DFS) and overall survival (OS) in patients with stage I–III colorectal cancer (CRC). The relationship between the CIPI and survival was evaluated using restricted cubic spli...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Hailun, Wei, Lishuang, Liu, Mingxiang, Liang, Yanren, Wang, Qiwen, Tang, Shuangyi, Gan, Jialiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593829/
https://www.ncbi.nlm.nih.gov/pubmed/37872322
http://dx.doi.org/10.1038/s41598-023-45550-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593829/
https://www.ncbi.nlm.nih.gov/pubmed/37872322
http://dx.doi.org/10.1038/s41598-023-45550-0

Ejemplares similares